Project Details
Projekt Print View

Molecular validation of novel Epstein-Barr virus (EBV) targets towards a lytic phase-directed antiviral drug development

Subject Area Virology
Term since 2025
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 566760749
 
No abstract available
DFG Programme Research Grants
 
 

Additional Information

Textvergrößerung und Kontrastanpassung